Total Funding
25
38
Total FundingGrant raised
Growth Score
-14 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
193643
Iconovo is a developer of inhalers for drugs that treat conditions such as asthma and COPD.
- Orest Lastow: Chief Technology Officer & FounderPast Role: Iconovo, CEO and Head of R&D
- Johan Wäborg: CEO
About the Company
ICONOVO is a Swedish privately funded device company with a business model to supply the market with unique, safe and cost efficient inhalation devices. ICONOVO has long and unique experience and capability in the development of inhalation devices. ICONOVO’s products combine technical complexity with user friendly and attractive design. ICONOVO’s
ambition is to become a leading supplier on a global market and to within 5 years achieve a multimillion turnover and a positive result.
